CAS 852918-02-6

Formel: C21H17ClFN3O4S

InChl: InChI=1S/C21H17ClFN3O4S/c22-18-12-17(10-11-19(18)23)31(29,30)24-13-14-6-8-16(9-7-14)21(28)26-25-20(27)15-4-2-1-3-5-15/h1-12,24H,13H2,(H,25,27)(H,26,28)

InChI Key: FYIBXBFDXNPBSF-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=C(C=C2)CNS(=O)(=O)C3=CC(=C(C=C3)F)Cl

TCN 201

CAS: 852918-02-6

TCN 201

Formel: C₂₁H₁₇ClFN₃O₄S

Reinheit: ≥98%

Molekulargewicht: 461.89

Ref: 54-BUP06204

3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulfonamide

CAS: 852918-02-6

Formel: C₂₁H₁₇ClFN₃O₄S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 461.8938

Ref: IN-DA00G577

TCN 201

CAS: 852918-02-6

TCN 201 is a selective antagonist of NMDA receptors containing the NR2A subunit.

Formel: C₂₁H₁₇ClFN₃O₄S

Reinheit: 98.5%

Farbe und Form: Solid

Molekulargewicht: 461.894

Ref: TM-T7870

TCN 201

Kontrolliertes Produkt

CAS: 852918-02-6

Applications TCN 201 is a novel NMDA receptor antagonist selective for NR2A- over NR2B-containing receptors.
References Auberson, Y., et al.: Bioorg. Med. Chem. Lett., 12, 1099 (2002), Yuan, H., et al.: J. Neurosci., 29, 12045 (2009), Bettini, et al.: J. Pharm. Exp. Ther., 335, 644 (2010), Hansen, et al.: J. Neurosci., 32, 6197 (2012),

Formel: C₂₁H₁₇ClFN₃O₄S

Farbe und Form: Neat

Molekulargewicht: 461.894

Ref: TR-T012550